The global mammography equipment market size was valued at USD 1.76 billion in 2025 and is projected to grow from USD 1.94 billion in 2026 to USD 4.19 billion by 2034, registering a CAGR of 10.12% during the forecast period from 2026 to 2034. North America dominated the mammography equipment market with a market share of 38.4% in 2025.
Mammography is an imaging technique that uses low-energy X-rays to examine the human breast for screening and diagnosis. The market is mainly driven by the rising prevalence of breast cancer, growing technological advancements in breast imaging, well-developed healthcare infrastructure, and increasing awareness regarding cancer among the population. As per the CDC, in the U.S. alone, about 245,000 cases of breast cancer are diagnosed every year, and it is the second leading cause of death across the country.
Download a Free Sample To learn more about this report,
Growing Adoption of 3D Imaging and AI-Assisted Detection
The mammography equipment market is moving toward digital breast tomosynthesis, artificial intelligence-assisted reading, and contrast-enhanced imaging. Tomosynthesis creates multiple low-dose images from different angles, helping radiologists examine overlapping breast tissue more clearly than standard two-dimensional mammography. AI tools are increasingly used as decision support to flag suspicious areas, prioritize examinations, and improve workflow, while radiologists retain final responsibility. Equipment designs are also emphasizing faster image acquisition, lower radiation exposure, improved patient positioning, and reduced discomfort. New breast-density reporting requirements are increasing demand for accurate imaging and consistent classification, especially because dense tissue can hide abnormalities and reduce mammography sensitivity.
Rising Breast Cancer Burden and Screening Programs Drive Demand
The high global burden of breast cancer is the main driver for mammography equipment demand. Early detection can identify abnormalities before symptoms develop, allowing treatment to begin when disease management may be more effective. Ageing populations, increased awareness, organized screening programs, and improved healthcare coverage are expanding examination volumes. Governments and hospitals are investing in digital systems to replace older film-based equipment and improve image storage, transfer, and comparison. Demand is also rising for diagnostic mammography after abnormal screening findings or clinical symptoms. Mobile screening units extend services to remote communities, while tomosynthesis and image-processing software help radiologists examine dense or overlapping breast tissue with greater confidence.
High Acquisition Costs and Unequal Screening Access Limit Adoption
Digital mammography and tomosynthesis systems require major investment in imaging equipment, workstations, detectors, software, installation, maintenance, and radiation-protection infrastructure. Facilities also need qualified mammographers, radiologists, and medical physicists, which adds to operating costs. Smaller hospitals and low-resource regions may not generate enough screening volume to justify advanced systems. Limited reimbursement can further delay replacement of older equipment. Patient barriers, including travel distance, examination discomfort, fear, and low awareness, can reduce screening participation even when machines are available. Dense breast tissue may also lower the sensitivity of mammography and lead to additional imaging, increasing costs and anxiety. These factors restrict equitable market expansion.
Mobile Screening and Emerging-Market Expansion Create Growth Potential
Large opportunities exist in mobile mammography, compact digital units, and screening networks serving rural and underserved populations. Portable installations can reduce travel barriers and help health systems reach women outside major hospitals. Equipment suppliers can also support replacement of ageing film-based and early-generation digital systems with lower-dose platforms, tomosynthesis, and secure image-sharing capabilities. AI-assisted workflow tools may help manage growing examination volumes where radiologist availability is limited, provided their accuracy is independently validated. Additional potential exists in contrast-enhanced mammography and risk-based screening for women with dense breasts or elevated cancer risk. Training, maintenance, remote support, and quality-assurance services can generate recurring revenue.
Workforce Shortages and Strict Quality Control Create Operational Pressure
Mammography requires precise positioning, reliable compression, stable image quality, and careful radiation-dose management. Poor positioning or equipment performance can produce unclear images, repeat examinations, and missed abnormalities. Screening providers must conduct regular quality checks, maintain detailed records, monitor equipment faults, and ensure personnel meet training requirements. Workforce shortages can create backlogs and increase pressure on radiologists and mammographers. AI integration adds challenges involving false findings, cybersecurity, software updates, bias, and compatibility with existing workstations. Differences in breast density and patient anatomy can also affect image interpretation. Manufacturers must therefore combine diagnostic performance, patient comfort, regulatory compliance, interoperability, and dependable technical service.
Digital mammography equipment is the leading product segment, accounting for a 58.6% market share, with a market value of USD 1.03 billion and a CAGR of 8.47%. Its strong market position is supported by the widespread shift from conventional imaging to digital systems that provide faster image processing, easier storage, and improved data sharing. Digital platforms also support integration with advanced diagnostic software and artificial intelligence tools, making them increasingly valuable in modern breast screening and diagnostic workflows. Growing breast cancer awareness, expanding screening programs, and continued investment in healthcare imaging infrastructure are further supporting demand for digital mammography equipment across hospitals and diagnostic facilities.
Analog mammography equipment continues to serve healthcare providers that rely on established imaging systems, particularly where technology upgrades are limited by budget or infrastructure constraints. However, the segment is gradually losing preference as healthcare facilities move toward more advanced digital solutions. Breast tomosynthesis equipment is gaining strong attention because it produces three-dimensional breast images that can help radiologists examine breast tissue more closely. Its growing use in screening and diagnostic applications is supported by increasing interest in advanced imaging, particularly for patients with dense breast tissue. The shift toward more detailed imaging and improved diagnostic confidence is expected to strengthen demand for tomosynthesis systems.
Request Customizationto receive a tailored report.
Breast imaging demand is strongest among individuals aged 41 to 60, representing a 54.8% market share, a market value of USD 0.96 billion, and a CAGR of 8.76%. This group holds a leading position because breast cancer risk generally increases with age, making regular screening increasingly important during this stage of life. Growing awareness of early detection and wider access to screening services are encouraging more people in this age group to undergo mammography examinations. Healthcare providers are also expanding screening capacity and adopting improved imaging technologies to support accurate diagnosis, helping sustain demand for mammography equipment in hospitals and diagnostic centers.
The 0 to 18 age group represents a smaller area of mammography use because routine mammographic screening is generally not targeted at children and adolescents. The 19 to 40 group may require breast imaging when symptoms, family history, or clinical concerns are present, although routine screening patterns differ from older populations. Meanwhile, people aged 60 and above remain an important user group because breast cancer risk continues to rise with age. Increased life expectancy, greater awareness among older adults, and continued participation in screening programs can support demand for breast imaging services across this population.
Hospitals represent the largest end-use segment, holding a 48.7% market share, with a market value of USD 0.86 billion and a CAGR of 8.23%. Their leading position is supported by the availability of specialized medical professionals, advanced diagnostic infrastructure, and comprehensive cancer care services. Hospitals often manage the complete patient pathway, from screening and diagnostic imaging to biopsy, treatment planning, and follow-up care. This integrated approach increases the need for reliable mammography systems and advanced breast imaging technologies. Continued investments in healthcare infrastructure, growing patient volumes, and the expansion of breast cancer screening services are expected to maintain hospitals as major users of mammography equipment.
Diagnostic laboratories play an important role in breast imaging by providing specialized screening and diagnostic services outside traditional hospital settings. Their growth is supported by increasing demand for faster testing, accessible imaging facilities, and specialized diagnostic expertise. Research centers also use mammography equipment to support clinical studies, imaging research, and the development of improved breast cancer detection methods. Ambulatory Surgical Centers are emerging as another important end-use setting as healthcare systems increasingly adopt outpatient care models. These facilities can benefit from efficient diagnostic workflows and advanced imaging capabilities that support timely patient assessment and coordinated clinical care.
Speak to an Analystto discuss market opportunities.
North America dominates the mammography equipment market with a 38.4% market share, representing a market value of USD 0.68 billion and a CAGR of 7.86%. The region benefits from advanced healthcare infrastructure, established breast cancer screening programs, and high adoption of modern diagnostic imaging technologies. Hospitals and diagnostic centers are increasingly upgrading their imaging systems to improve screening efficiency and diagnostic accuracy. Growing awareness of early breast cancer detection and continued investment in healthcare technology are also supporting demand for advanced mammography equipment across the region.
The United States is a leading market in North America, supported by advanced hospitals, diagnostic centers, and specialized breast imaging facilities. The country has strong screening infrastructure and high awareness of breast cancer prevention and early detection. Healthcare providers are increasingly adopting digital mammography, breast tomosynthesis, and AI-supported imaging solutions to improve diagnostic workflows. The presence of major medical technology companies and strong research capabilities also encourages innovation in breast imaging. Continued investments in healthcare modernization and growing demand for efficient screening services are expected to support the adoption of advanced mammography equipment.
Canada's mammography equipment market is supported by its well-developed healthcare system and organized breast cancer screening initiatives. Healthcare providers are focusing on improving access to breast imaging services across different communities, including underserved areas. The adoption of digital mammography and advanced imaging technologies is helping facilities improve image management and diagnostic workflows. Growing public awareness of breast cancer and the importance of early detection is also supporting demand for screening services. Continued improvements in healthcare infrastructure and investments in modern diagnostic equipment are expected to strengthen the use of mammography systems across Canadian healthcare facilities.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific is the fastest-growing region in the mammography equipment market, with a CAGR of 10.21%, while holding a 22.8% market share and a market value of USD 0.4 billion. Regional growth is supported by increasing breast cancer awareness, expanding healthcare infrastructure, and greater access to screening and diagnostic services. Governments and healthcare providers are working to improve cancer detection and strengthen medical facilities. Hospitals and diagnostic centers are increasingly adopting digital mammography and advanced imaging technologies. The region's large population and growing healthcare investment create significant opportunities for equipment manufacturers and service providers.
Japan has a mature healthcare system with strong medical imaging capabilities and a growing focus on preventive healthcare. Its aging population and increased attention to early cancer detection support continued demand for breast screening services. Hospitals and diagnostic centers are adopting modern imaging technologies to improve the quality and efficiency of breast cancer diagnosis. Japan's strong technology sector also supports innovation in digital healthcare and AI-assisted medical imaging. Healthcare providers are increasingly interested in solutions that can improve screening workflows and assist radiologists in evaluating complex cases. These developments are supporting the modernization of mammography equipment across the country.
China represents a major opportunity for mammography equipment manufacturers due to expanding healthcare infrastructure and increasing awareness of breast cancer. Hospitals and diagnostic centers are investing in advanced imaging technologies to improve early detection and diagnostic capabilities. Growing public health awareness is encouraging more women to access breast screening services. Healthcare development in smaller cities and developing regions is also creating opportunities to expand access to modern breast imaging. In addition, domestic medical technology development and the adoption of advanced digital solutions are strengthening the country's diagnostic capabilities. Continued healthcare modernization is expected to support the use of mammography equipment.
Europe holds a 27.6% market share in the mammography equipment market, with a market value of USD 0.49 billion and a CAGR of 7.94%. The region benefits from established healthcare systems, organized breast cancer screening programs, and strong access to diagnostic imaging services. Healthcare providers are increasingly adopting digital mammography and advanced breast imaging solutions to improve diagnostic accuracy and workflow efficiency. Growing interest in artificial intelligence and data-driven healthcare is also supporting technology development. Continued modernization of hospitals and diagnostic centers, combined with strong awareness of early cancer detection, is expected to maintain demand for advanced mammography equipment across Europe.
Germany has a well-established healthcare system with extensive hospital networks and specialized diagnostic facilities. The country places strong emphasis on preventive healthcare and organized breast cancer screening, supporting the use of mammography equipment. Healthcare providers are increasingly adopting digital imaging and advanced diagnostic technologies to improve screening and clinical decision-making. Germany's strong medical technology industry also contributes to innovation in breast imaging solutions. Artificial intelligence and digital data management are gaining attention as healthcare facilities seek to improve diagnostic workflows. Continued investment in healthcare modernization and early cancer detection is expected to support the adoption of advanced mammography systems.
The United Kingdom benefits from established breast cancer screening services and extensive healthcare infrastructure. The National Health Service plays an important role in providing access to breast screening and diagnostic services. Healthcare facilities are increasingly focused on modernizing imaging equipment and improving screening workflows. Digital mammography and advanced imaging technologies are becoming more important as providers seek to support accurate and timely diagnosis. The country is also exploring the potential use of artificial intelligence in medical imaging, creating opportunities for technology integration. Continued attention to early detection, screening accessibility, and healthcare modernization is expected to support demand for mammography equipment.
The Middle East and Africa region holds a 4.9% market share in the mammography equipment market, with a market value of USD 0.09 billion and a CAGR of 7.48%. Growing awareness of breast cancer and increasing efforts to improve early diagnosis are supporting demand for mammography equipment. Healthcare infrastructure development, particularly in developed Middle Eastern markets, is encouraging the installation of modern diagnostic systems. Healthcare providers are also investing in screening programs and advanced imaging technologies. However, differences in healthcare infrastructure and access to specialized services remain challenges across the region. Continued investment in hospitals, diagnostic centers, and preventive healthcare is creating opportunities for market growth.
The UAE is developing its healthcare sector through investments in modern hospitals, specialized medical centers, and advanced diagnostic technologies. The country is placing greater emphasis on preventive healthcare and early cancer detection, supporting the expansion of breast screening services. Healthcare providers are adopting sophisticated imaging systems to improve diagnostic capabilities and patient care. The country's growing medical tourism sector also encourages healthcare facilities to maintain high-quality diagnostic infrastructure. Digital healthcare initiatives and increasing interest in artificial intelligence-based medical solutions may further support innovation in breast imaging. Continued healthcare modernization and growing awareness of breast cancer screening are expected to strengthen demand for modern mammography equipment.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Artificial Lung Market Size, Share, Growth, Analysis, 2034
Bronchoscopes Market Size, Share, Growth, Analysis, Report, 2034
Aesthetic Threads Market Size, Share, Growth, Forecast, 2034
Middle East And Africa Diabetes Devices Market Size and Forecast 2034
Bladder Scanners Market Size, Share, Growth, Forecast, 2034
Japan Dialyzer Market Size, Top Share, Demand And Forecast to 2034
We are featured on:
sales@straitsresearch.com